Back
Gold Royalty Vs. PTC Therapeutics Industry Stock Comparison
Sell
9
GROY
Gold Royalty
Last Price:
1.42
Seasonality Move:
-15.48%
Sell
35
PTCT
PTC Therapeutics
Last Price:
30.84
Seasonality Move:
8.27%
Sell
9
Gold Royalty (GROY)
is a Sell
Is Gold Royalty a Buy, Sell or Hold?
- The current Gold Royalty [GROY] share price is $1.41. The Score for GROY is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- GROY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $30.58. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GROY Stock Price Chart
What is Gold Royalty's stock price today?
-
The Gold Royalty share price today is $1.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GROY is experiencing slight buying pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $30.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
GROY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 39.23 | Sell |
| Chaikin Money Flow: | 148642 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.37 - 1.65) | Sell |
| Bollinger Bands (100): | (1.54 - 2) | Sell |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 34.74 | Sell |
| Chaikin Money Flow: | 26543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.49 - 37.71) | Sell |
| Bollinger Bands (100): | (26.63 - 35.17) | Sell |
GROY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.4 | Buy |
| 20-day SMA: | 1.47 | Sell |
| 50-day SMA: | 1.73 | Sell |
| 200-day SMA: | 1.58 | Sell |
| 8-day EMA: | 1.41 | Buy |
| 20-day EMA: | 1.48 | Sell |
| 50-day EMA: | 1.63 | Sell |
| 200-day EMA: | 1.71 | Sell |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.57 | Sell |
| 20-day SMA: | 36.04 | Sell |
| 50-day SMA: | 33.78 | Sell |
| 200-day SMA: | 27.65 | Buy |
| 8-day EMA: | 34.28 | Sell |
| 20-day EMA: | 35.15 | Sell |
| 50-day EMA: | 33.95 | Sell |
| 200-day EMA: | 31.82 | Sell |
Gold Royalty Earnings Growth & GROY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.01 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.53 per share, and an increase next year of $2.08 per share.
Gold Royalty Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||